Multimodal Imaging Market is expected to reach US$ 4.88 Bn. by 2029, at a CAGR of 5.2% during the forecast period.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report Multimodal imaging has developed drastically in recent times owing to the rapid increase in the geriatric population and technological advancements in the development of imaging systems, this industry has witnessed a steady growth. Further, significant opportunities from emerging economies have helped to improve the adoption of multimodal imaging systems. The report covers all the trends and technologies playing a major role in the growth of the multimodal imaging market during the forecast period. It highlights the drivers, restraints, and opportunities expected to influence market growth during 2023-2029. Diagnostic imaging centers segment held the dominant xx% market share in 2022. The diagnostic technique is also used in small animal imaging for drug discovery and development procedures. The technique helps in empathetic dynamic biological procedures, gene expression, enzyme and protein activity, progression, treatment of diseases, biodistribution, pharmacodynamics or pharmacokinetics of drug molecule in model organisms. Such imaging data assist researchers in the study of the fundamental aspects of human-system function and dysfunction. PET/CT segment holds the largest xx% market share and expected to dominate the market during the forecast period. The increasing demand for early and accurate cancer diagnosis, growing clinical evidence for the early detection of Alzheimer’s disease, increasing applications of PET/CT systems in cardiology, favorable reimbursement scenario, and the technological advancements in the field of PET/CT. In terms of region, the Asia-Pacific will be the fastest-growing regional market owing to the accelerated economic growth of many countries in this region; growing government focus on the healthcare sector, and rising pharmaceutical research activities. Also, government initiatives towards the development of healthcare facilities and increasing health insurance penetration are the key factors propelling the growth of the Asia-Pacific multimodal imaging market. The report covers the recent development in the global multimodal imaging market like in 2022, MR Solutions Ltd. launched pre-clinical CT scan models for serial multimodal imaging with MRI and CT scanners. In 2022, Siemens Healthineers, a part of Siemens AG launched Biograph Vision PET/CT system with reduced crystal elements, proposing a higher spatial resolution that improves lesion detectability in cancer diagnosis. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Multimodal Imaging Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in Global Multimodal Imaging Market.
Multimodal Imaging Market Scope: Inquire before buying
Multimodal Imaging Market Base Year 2022 Forecast Period 2023-2029 Historical Data CAGR Market Size in 2022 Market Size in 2029 2018 to 2022 5.2% US$ 3.42 Bn US$ 4.88 Bn Segments Covered by Technology PET/CT Systems SPECT/CT Systems PET/MR Systems OCT/Fundus Imaging Systems Other Multimodal Imaging Systems by Application Brain & Neurology Cardiology Oncology Ophthalmology Other Applications by End User Hospitals Diagnostic Imaging Centers Other End Users Regions Covered North America United States Canada Mexico Europe UK France Germany Italy Spain Sweden Austria Rest of Europe Asia Pacific China S Korea Japan India Australia Indonesia Malaysia Vietnam Taiwan Bangladesh Pakistan Rest of APAC Middle East and Africa South Africa GCC Egypt Nigeria Rest of ME&A South America Brazil Argentina Rest of South America Multimodal Imaging Market Key Players
1.Siemens AG 2.GE Healthcare 3.Koninklijke Philips N.V. 4.Bruker Corporation 5.Canon Inc. 6.Mediso Ltd. 7.MILabs B.V. 8.MR Solutions Ltd. 9.Northridge Tri-Modality Imaging, Inc. 10.PerkinElmer, Inc. 11.Shanghai United Imaging Healthcare Co., Ltd. 12.Appendix 13.Questionnaire 14.Available Customization 15.Heidelberg Engineering Inc. 16.Carl Zeiss AG. 17.Topcon Corporation 18.Spectrum Dynamics Medical. 19.Siemens AG 20.Barco 21.FUJIFILM VisualSonics Inc 22.Surface Optics Corporation
Frequently Asked Questions: 1. Which region has the largest share in Global Multimodal Imaging Market? Ans: Asia Pacific region held the highest share in 2022. 2. What is the growth rate of Global Multimodal Imaging Market? Ans: The Global Multimodal Imaging Market is growing at a CAGR of 5.2% during forecasting period 2023-2029. 3. What is scope of the Global Multimodal Imaging market report? Ans: Global Multimodal Imaging Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Multimodal Imaging market? Ans: The important key players in the Global Multimodal Imaging Market are – Siemens AG, GE Healthc, Koninklijke Philips N.V., Bruker Corporation, Canon Inc., Mediso Ltd., MILabs B.V., MR Solutions Ltd., Northridge Tri-Modality Imaging, Inc., PerkinElmer, Inc., Shanghai United Imaging Healthcare Co., Ltd., Appendix, Questionnaire, Available Customization, Heidelberg Engineering Inc., Carl Zeiss AG., Topcon Corporation, Spectrum Dynamics Medical., Siemens AG, Barco, FUJIFILM VisualSonics Inc, and Surface Optics Corporation 5. What is the study period of this market? Ans: The Global Multimodal Imaging Market is studied from 2022 to 2029.
Multimodal Imaging Market
Table of Content 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Multimodal Imaging Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Multimodal Imaging Market Analysis and Forecast 6.1. Multimodal Imaging Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Multimodal Imaging Market Analysis and Forecast, by Technology 7.1. Introduction and Definition 7.2. Key Findings 7.3. Multimodal Imaging Market Value Share Analysis, by Technology 7.4. Multimodal Imaging Market Size (US$ Bn) Forecast, by Technology 7.5. Multimodal Imaging Market Analysis, by Technology 7.6. Multimodal Imaging Market Attractiveness Analysis, by Technology 8. Multimodal Imaging Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Multimodal Imaging Market Value Share Analysis, by Application 8.4. Multimodal Imaging Market Size (US$ Bn) Forecast, by Application 8.5. Multimodal Imaging Market Analysis, by Application 8.6. Multimodal Imaging Market Attractiveness Analysis, by Application 9. Multimodal Imaging Market Analysis and Forecast, by End-User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Multimodal Imaging Market Value Share Analysis, by End-User 9.4. Multimodal Imaging Market Size (US$ Bn) Forecast, by End-User 9.5. Multimodal Imaging Market Analysis, by End-User 9.6. Multimodal Imaging Market Attractiveness Analysis, by End-User 10. Multimodal Imaging Market Analysis, by Region 10.1. Multimodal Imaging Market Value Share Analysis, by Region 10.2. Multimodal Imaging Market Size (US$ Bn) Forecast, by Region 10.3. Multimodal Imaging Market Attractiveness Analysis, by Region 11. North America Multimodal Imaging Market Analysis 11.1. Key Findings 11.2. North America Multimodal Imaging Market Overview 11.3. North America Multimodal Imaging Market Value Share Analysis, by Technology 11.4. North America Multimodal Imaging Market Forecast, by Technology 11.4.1. PET/CT Systems 11.4.2. SPECT/CT Systems 11.4.3. PET/MR Systems 11.4.4. OCT/Fundus Imaging Systems 11.4.5. Other Multimodal Imaging System 11.5. North America Multimodal Imaging Market Value Share Analysis, by Application 11.6. North America Multimodal Imaging Market Forecast, by Application 11.6.1. Brain & Neurology 11.6.2. Cardiology 11.6.3. Oncology 11.6.4. Ophthalmology 11.6.5. Other Application 11.7. North America Multimodal Imaging Market Value Share Analysis, by End-User 11.8. North America Multimodal Imaging Market Forecast, by End-User 11.8.1. Hospitals 11.8.2. Diagnostic Imaging Centers 11.8.3. Other End Users 11.9. North America Multimodal Imaging Market Value Share Analysis, by Country 11.10. North America Multimodal Imaging Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Multimodal Imaging Market Analysis, by Country 11.12. U.S. Multimodal Imaging Market Forecast, by Technology 11.12.1. PET/CT Systems 11.12.2. SPECT/CT Systems 11.12.3. PET/MR Systems 11.12.4. OCT/Fundus Imaging Systems 11.12.5. Other Multimodal Imaging System 11.13. U.S. Multimodal Imaging Market Forecast, by Application 11.13.1. Brain & Neurology 11.13.2. Cardiology 11.13.3. Oncology 11.13.4. Ophthalmology 11.13.5. Other Application 11.14. U.S. Multimodal Imaging Market Forecast, by End-User 11.14.1. Hospitals 11.14.2. Diagnostic Imaging Centers 11.14.3. Other End Users 11.15. Canada Multimodal Imaging Market Forecast, by Technology 11.15.1. PET/CT Systems 11.15.2. SPECT/CT Systems 11.15.3. PET/MR Systems 11.15.4. OCT/Fundus Imaging Systems 11.15.5. Other Multimodal Imaging System 11.16. Steel Canada Multimodal Imaging Market Forecast, by Application 11.16.1. Brain & Neurology 11.16.2. Cardiology 11.16.3. Oncology 11.16.4. Ophthalmology 11.16.5. Other Application 11.17. Canada Multimodal Imaging Market Forecast, by End-User 11.17.1. Hospitals 11.17.2. Diagnostic Imaging Centers 11.17.3. Other End Users 11.18. North America Multimodal Imaging Market Attractiveness Analysis 11.18.1. By Technology 11.18.2. By Application 11.18.3. By End-User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Multimodal Imaging Market Analysis 12.1. Key Findings 12.2. Europe Multimodal Imaging Market Overview 12.3. Europe Multimodal Imaging Market Value Share Analysis, by Technology 12.4. Europe Multimodal Imaging Market Forecast, by Technology 12.4.1. PET/CT Systems 12.4.2. SPECT/CT Systems 12.4.3. PET/MR Systems 12.4.4. OCT/Fundus Imaging Systems 12.4.5. Other Multimodal Imaging System 12.5. Europe Multimodal Imaging Market Value Share Analysis, by Application 12.6. Europe Multimodal Imaging Market Forecast, by Application 12.6.1. Brain & Neurology 12.6.2. Cardiology 12.6.3. Oncology 12.6.4. Ophthalmology 12.6.5. Other Application 12.7. Europe Multimodal Imaging Market Value Share Analysis, by End-User 12.8. Europe Multimodal Imaging Market Forecast, by End-User 12.8.1. Hospitals 12.8.2. Diagnostic Imaging Centers 12.8.3. Other End Users 12.9. Europe Multimodal Imaging Market Value Share Analysis, by Country 12.10. Europe Multimodal Imaging Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Multimodal Imaging Market Analysis, by Country 12.12. Germany Multimodal Imaging Market Forecast, by Technology 12.12.1. PET/CT Systems 12.12.2. SPECT/CT Systems 12.12.3. PET/MR Systems 12.12.4. OCT/Fundus Imaging Systems 12.12.5. Other Multimodal Imaging System 12.13. Germany Multimodal Imaging Market Forecast, by Application 12.13.1. Brain & Neurology 12.13.2. Cardiology 12.13.3. Oncology 12.13.4. Ophthalmology 12.13.5. Other Application 12.14. Germany Multimodal Imaging Market Forecast, by End-User 12.14.1. Hospitals 12.14.2. Diagnostic Imaging Centers 12.14.3. Other End Users 12.15. U.K. Multimodal Imaging Market Forecast, by Technology 12.15.1. PET/CT Systems 12.15.2. SPECT/CT Systems 12.15.3. PET/MR Systems 12.15.4. OCT/Fundus Imaging Systems 12.15.5. Other Multimodal Imaging System 12.16. U.K. Multimodal Imaging Market Forecast, by Application 12.16.1. Brain & Neurology 12.16.2. Cardiology 12.16.3. Oncology 12.16.4. Ophthalmology 12.16.5. Other Application 12.17. U.K. Multimodal Imaging Market Forecast, by End-User 12.17.1. Hospitals 12.17.2. Diagnostic Imaging Centers 12.17.3. Other End Users 12.18. France Multimodal Imaging Market Forecast, by Technology 12.18.1. PET/CT Systems 12.18.2. SPECT/CT Systems 12.18.3. PET/MR Systems 12.18.4. OCT/Fundus Imaging Systems 12.18.5. Other Multimodal Imaging System 12.19. France Multimodal Imaging Market Forecast, by Application 12.19.1. Brain & Neurology 12.19.2. Cardiology 12.19.3. Oncology 12.19.4. Ophthalmology 12.19.5. Other Application 12.20. France Multimodal Imaging Market Forecast, by End-User 12.20.1. Hospitals 12.20.2. Diagnostic Imaging Centers 12.20.3. Other End Users 12.21. Italy Multimodal Imaging Market Forecast, by Technology 12.21.1. PET/CT Systems 12.21.2. SPECT/CT Systems 12.21.3. PET/MR Systems 12.21.4. OCT/Fundus Imaging Systems 12.21.5. Other Multimodal Imaging System 12.22. Italy Multimodal Imaging Market Forecast, by Application 12.22.1. Brain & Neurology 12.22.2. Cardiology 12.22.3. Oncology 12.22.4. Ophthalmology 12.22.5. Other Application 12.23. Italy Multimodal Imaging Market Forecast, by End-User 12.23.1. Hospitals 12.23.2. Diagnostic Imaging Centers 12.23.3. Other End Users 12.24. Spain Multimodal Imaging Market Forecast, by Technology 12.24.1. PET/CT Systems 12.24.2. SPECT/CT Systems 12.24.3. PET/MR Systems 12.24.4. OCT/Fundus Imaging Systems 12.24.5. Other Multimodal Imaging System 12.25. Spain Multimodal Imaging Market Forecast, by Application 12.25.1. Brain & Neurology 12.25.2. Cardiology 12.25.3. Oncology 12.25.4. Ophthalmology 12.25.5. Other Application 12.26. Spain Multimodal Imaging Market Forecast, by End-User 12.26.1. Hospitals 12.26.2. Diagnostic Imaging Centers 12.26.3. Other End Users 12.27. Rest of Europe Multimodal Imaging Market Forecast, by Technology 12.27.1. PET/CT Systems 12.27.2. SPECT/CT Systems 12.27.3. PET/MR Systems 12.27.4. OCT/Fundus Imaging Systems 12.27.5. Other Multimodal Imaging 12.28. Rest of Europe Multimodal Imaging Market Forecast, by Application 12.28.1. Brain & Neurology 12.28.2. Cardiology 12.28.3. Oncology 12.28.4. Ophthalmology 12.28.5. Other Application 12.29. Rest Of Europe Multimodal Imaging Market Forecast, by End-User 12.29.1. Hospitals 12.29.2. Diagnostic Imaging Centers 12.29.3. Other End Users 12.30. Europe Multimodal Imaging Market Attractiveness Analysis 12.30.1. By Technology 12.30.2. By Application 12.30.3. By End-User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Multimodal Imaging Market Analysis 13.1. Key Findings 13.2. Asia Pacific Multimodal Imaging Market Overview 13.3. Asia Pacific Multimodal Imaging Market Value Share Analysis, by Technology 13.4. Asia Pacific Multimodal Imaging Market Forecast, by Technology 13.4.1. PET/CT Systems 13.4.2. SPECT/CT Systems 13.4.3. PET/MR Systems 13.4.4. OCT/Fundus Imaging Systems 13.4.5. Other Multimodal Imaging 13.5. Asia Pacific Multimodal Imaging Market Value Share Analysis, by Application 13.6. Asia Pacific Multimodal Imaging Market Forecast, by Application 13.6.1. Brain & Neurology 13.6.2. Cardiology 13.6.3. Oncology 13.6.4. Ophthalmology 13.6.5. Other Application 13.7. Asia Pacific Multimodal Imaging Market Value Share Analysis, by End-User 13.8. Asia Pacific Multimodal Imaging Market Forecast, by End-User 13.8.1. Hospitals 13.8.2. Diagnostic Imaging Centers 13.8.3. Other End Users 13.9. Asia Pacific Multimodal Imaging Market Value Share Analysis, by Country 13.10. Asia Pacific Multimodal Imaging Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Multimodal Imaging Market Analysis, by Country 13.12. China Multimodal Imaging Market Forecast, by Technology 13.12.1. PET/CT Systems 13.12.2. SPECT/CT Systems 13.12.3. PET/MR Systems 13.12.4. OCT/Fundus Imaging Systems 13.12.5. Other Multimodal Imaging 13.13. China Multimodal Imaging Market Forecast, by Application 13.13.1. Brain & Neurology 13.13.2. Cardiology 13.13.3. Oncology 13.13.4. Ophthalmology 13.13.5. Other Application 13.14. China Multimodal Imaging Market Forecast, by End-User 13.14.1. Hospitals 13.14.2. Diagnostic Imaging Centers 13.14.3. Other End Users 13.15. India Multimodal Imaging Market Forecast, by Technology 13.15.1. PET/CT Systems 13.15.2. SPECT/CT Systems 13.15.3. PET/MR Systems 13.15.4. OCT/Fundus Imaging Systems 13.15.5. Other Multimodal Imaging 13.16. India Multimodal Imaging Market Forecast, by Application 13.16.1. Brain & Neurology 13.16.2. Cardiology 13.16.3. Oncology 13.16.4. Ophthalmology 13.16.5. Other Application 13.17. India Multimodal Imaging Market Forecast, by End-User 13.17.1. Hospitals 13.17.2. Diagnostic Imaging Centers 13.17.3. Other End Users 13.18. Japan Multimodal Imaging Market Forecast, by Technology 13.18.1. PET/CT Systems 13.18.2. SPECT/CT Systems 13.18.3. PET/MR Systems 13.18.4. OCT/Fundus Imaging Systems 13.18.5. Other Multimodal Imaging 13.19. Japan Multimodal Imaging Market Forecast, by Application 13.19.1. Brain & Neurology 13.19.2. Cardiology 13.19.3. Oncology 13.19.4. Ophthalmology 13.19.5. Other Application 13.20. Japan Multimodal Imaging Market Forecast, by End-User 13.20.1. Hospitals 13.20.2. Diagnostic Imaging Centers 13.20.3. Other End Users 13.21. ASEAN Multimodal Imaging Market Forecast, by Technology 13.21.1. PET/CT Systems 13.21.2. SPECT/CT Systems 13.21.3. PET/MR Systems 13.21.4. OCT/Fundus Imaging Systems 13.21.5. Other Multimodal Imaging 13.22. ASEAN Multimodal Imaging Market Forecast, by Application 13.22.1. Brain & Neurology 13.22.2. Cardiology 13.22.3. Oncology 13.22.4. Ophthalmology 13.22.5. Other Application 13.23. ASEAN Multimodal Imaging Market Forecast, by End-User 13.23.1. Hospitals 13.23.2. Diagnostic Imaging Centers 13.23.3. Other End Users 13.24. Rest of Asia Pacific Multimodal Imaging Market Forecast, by Technology 13.24.1. PET/CT Systems 13.24.2. SPECT/CT Systems 13.24.3. PET/MR Systems 13.24.4. OCT/Fundus Imaging Systems 13.24.5. Other Multimodal Imaging 13.25. Rest of Asia Pacific Multimodal Imaging Market Forecast, by Application 13.25.1. Brain & Neurology 13.25.2. Cardiology 13.25.3. Oncology 13.25.4. Ophthalmology 13.25.5. Other Application 13.26. Rest of Asia Pacific Multimodal Imaging Market Forecast, by End-User 13.26.1. Hospitals 13.26.2. Diagnostic Imaging Centers 13.26.3. Other End Users 13.27. Asia Pacific Multimodal Imaging Market Attractiveness Analysis 13.27.1. By Technology 13.27.2. By Application 13.27.3. By End-User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Multimodal Imaging Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Multimodal Imaging Market Overview 14.3. Middle East & Africa Multimodal Imaging Market Value Share Analysis, by Technology 14.4. Middle East & Africa Multimodal Imaging Market Forecast, by Technology 14.4.1. PET/CT Systems 14.4.2. SPECT/CT Systems 14.4.3. PET/MR Systems 14.4.4. OCT/Fundus Imaging Systems 14.4.5. Other Multimodal Imaging 14.5. Middle East & Africa Multimodal Imaging Market Value Share Analysis, by Application 14.6. Middle East & Africa Multimodal Imaging Market Forecast, by Application 14.6.1. Brain & Neurology 14.6.2. Cardiology 14.6.3. Oncology 14.6.4. Ophthalmology 14.6.5. Other Application 14.7. Middle East & Africa Multimodal Imaging Market Value Share Analysis, by End-User 14.8. Middle East & Africa Multimodal Imaging Market Forecast, by End-User 14.8.1. Hospitals 14.8.2. Diagnostic Imaging Centers 14.8.3. Other End Users 14.9. Middle East & Africa Multimodal Imaging Market Value Share Analysis, by Country 14.10. Middle East & Africa Multimodal Imaging Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Multimodal Imaging Market Analysis, by Country 14.12. GCC Multimodal Imaging Market Forecast, by Technology 14.12.1. PET/CT Systems 14.12.2. SPECT/CT Systems 14.12.3. PET/MR Systems 14.12.4. OCT/Fundus Imaging Systems 14.12.5. Other Multimodal Imaging 14.13. GCC Multimodal Imaging Market Forecast, by Application 14.13.1. Brain & Neurology 14.13.2. Cardiology 14.13.3. Oncology 14.13.4. Ophthalmology 14.13.5. Other Application 14.14. GCC Multimodal Imaging Market Forecast, by End-User 14.14.1. Hospitals 14.14.2. Diagnostic Imaging Centers 14.14.3. Other End Users 14.15. South Africa Multimodal Imaging Market Forecast, by Technology 14.15.1. PET/CT Systems 14.15.2. SPECT/CT Systems 14.15.3. PET/MR Systems 14.15.4. OCT/Fundus Imaging Systems 14.15.5. Other Multimodal Imaging 14.16. South Africa Multimodal Imaging Market Forecast, by Application 14.16.1. Brain & Neurology 14.16.2. Cardiology 14.16.3. Oncology 14.16.4. Ophthalmology 14.16.5. Other Application 14.17. South Africa Multimodal Imaging Market Forecast, by End-User 14.17.1. Hospitals 14.17.2. Diagnostic Imaging Centers 14.17.3. Other End Users 14.18. Rest of Middle East & Africa Multimodal Imaging Market Forecast, by Technology 14.18.1. PET/CT Systems 14.18.2. SPECT/CT Systems 14.18.3. PET/MR Systems 14.18.4. OCT/Fundus Imaging Systems 14.18.5. Other Multimodal Imaging 14.19. Rest of Middle East & Africa Multimodal Imaging Market Forecast, by Application 14.19.1. Brain & Neurology 14.19.2. Cardiology 14.19.3. Oncology 14.19.4. Ophthalmology 14.19.5. Other Application 14.20. Rest of Middle East & Africa Multimodal Imaging Market Forecast, by End-User 14.20.1. Hospitals 14.20.2. Diagnostic Imaging Centers 14.20.3. Other End Users 14.21. Middle East & Africa Multimodal Imaging Market Attractiveness Analysis 14.21.1. By Technology 14.21.2. By Application 14.21.3. By End-User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Multimodal Imaging Market Analysis 15.1. Key Findings 15.2. South America Multimodal Imaging Market Overview 15.3. South America Multimodal Imaging Market Value Share Analysis, by Technology 15.4. South America Multimodal Imaging Market Forecast, by Technology 15.4.1. PET/CT Systems 15.4.2. SPECT/CT Systems 15.4.3. PET/MR Systems 15.4.4. OCT/Fundus Imaging Systems 15.4.5. Other Multimodal Imaging 15.5. South America Multimodal Imaging Market Value Share Analysis, by Application 15.6. South America Multimodal Imaging Market Forecast, by Application 15.6.1. Brain & Neurology 15.6.2. Cardiology 15.6.3. Oncology 15.6.4. Ophthalmology 15.6.5. Other Application 15.7. South America Multimodal Imaging Market Value Share Analysis, by End-User 15.8. South America Multimodal Imaging Market Forecast, by End-User 15.8.1. Hospitals 15.8.2. Diagnostic Imaging Centers 15.8.3. Other End Users 15.9. South America Multimodal Imaging Market Value Share Analysis, by Country 15.10. South America Multimodal Imaging Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Multimodal Imaging Market Analysis, by Country 15.12. Brazil Multimodal Imaging Market Forecast, by Technology 15.12.1. PET/CT Systems 15.12.2. SPECT/CT Systems 15.12.3. PET/MR Systems 15.12.4. OCT/Fundus Imaging Systems 15.12.5. Other Multimodal Imaging 15.13. Brazil Multimodal Imaging Market Forecast, by Application 15.13.1. Brain & Neurology 15.13.2. Cardiology 15.13.3. Oncology 15.13.4. Ophthalmology 15.13.5. Other Application 15.14. Brazil Multimodal Imaging Market Forecast, by End-User 15.14.1. Hospitals 15.14.2. Diagnostic Imaging Centers 15.14.3. Other End Users 15.15. Mexico Multimodal Imaging Market Forecast, by Technology 15.15.1. PET/CT Systems 15.15.2. SPECT/CT Systems 15.15.3. PET/MR Systems 15.15.4. OCT/Fundus Imaging Systems 15.15.5. Other Multimodal Imaging 15.16. Mexico Multimodal Imaging Market Forecast, by Application 15.16.1. Brain & Neurology 15.16.2. Cardiology 15.16.3. Oncology 15.16.4. Ophthalmology 15.16.5. Other Application 15.17. Mexico Multimodal Imaging Market Forecast, by End-User 15.17.1. Hospitals 15.17.2. Diagnostic Imaging Centers 15.17.3. Other End Users 15.18. Rest of South America Multimodal Imaging Market Forecast, by Technology 15.18.1. PET/CT Systems 15.18.2. SPECT/CT Systems 15.18.3. PET/MR Systems 15.18.4. OCT/Fundus Imaging Systems 15.18.5. Other Multimodal Imaging 15.19. Rest of South America Multimodal Imaging Market Forecast, by Application 15.19.1. Brain & Neurology 15.19.2. Cardiology 15.19.3. Oncology 15.19.4. Ophthalmology 15.19.5. Other Application 15.20. Rest of South America Multimodal Imaging Market Forecast, by End-User 15.20.1. Hospitals 15.20.2. Diagnostic Imaging Centers 15.20.3. Other End Users 15.21. South America Multimodal Imaging Market Attractiveness Analysis 15.21.1. By Technology 15.21.2. By Application 15.21.3. By End-User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Siemens AG 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. GE Healthc 16.3.3. Koninklijke Philips N.V. 16.3.4. Bruker Corporation 16.3.5. Canon Inc. 16.3.6. Mediso Ltd. 16.3.7. MILabs B.V. 16.3.8. MR Solutions Ltd. 16.3.9. Northridge Tri-Modality Imaging, Inc. 16.3.10. PerkinElmer, Inc. 16.3.11. Shanghai United Imaging Healthcare Co., Ltd. 16.3.12. Appendix 16.3.13. Questionnaire 16.3.14. Available Customization 16.3.15. Heidelberg Engineering Inc. 16.3.16. Carl Zeiss AG. 16.3.17. Topcon Corporation 16.3.18. Spectrum Dynamics Medical. 16.3.19. Siemens AG 16.3.20. Barco 16.3.21. FUJIFILM VisualSonics Inc 16.3.22. Surface Optics Corporation 17. Primary Key Insights